Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases

• Published in: Nutrients 2023-04, Vol.15 (8), p.1850
• Main Authors: Yntema, Tess, Koonen, Debby P Y, Kuipers, Folkert
• Format: Article
• Language: English
• Subjects: Arteriosclerosis; Atherosclerosis; Bacteria; Bile; Bile acids; Bile Acids and Salts; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - etiology; Cardiovascular Diseases - metabolism; Causes of; Cholesterol; Colon; Cytochrome; Digestive system; Enzymes; Gallbladder; Gastrointestinal Microbiome; Gastrointestinal system; gut microbiota; Health aspects; Health services; Heart function; Humans; Hypertension; Hypertension - complications; Inflammation; Intestinal absorption; Intestinal microflora; Lipid metabolism; Lipids; Liver; Metabolism; Metabolites; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Molecular modelling; Oxidation; Physiological aspects; Review; Risk factors; Small intestine; Sterols; Therapeutic targets; Trimethylamine; Trimethylamine-N-oxide; Vein & artery diseases; Vitamins
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15081850

Despite advances in preventive measures and treatment options, cardiovascular disease (CVD) remains the number one cause of death globally. Recent research has challenged the traditional risk factor profile and highlights the potential contribution of non-traditional factors in CVD, such as the gut microbiota and its metabolites. Disturbances in the gut microbiota have been repeatedly associated with CVD, including atherosclerosis and hypertension. Mechanistic studies support a causal role of microbiota-derived metabolites in disease development, such as short-chain fatty acids, trimethylamine-N-oxide, and bile acids, with the latter being elaborately discussed in this review. Bile acids represent a class of cholesterol derivatives that is essential for intestinal absorption of lipids and fat-soluble vitamins, plays an important role in cholesterol turnover and, as more recently discovered, acts as a group of signaling molecules that exerts hormonal functions throughout the body. Studies have shown mediating roles of bile acids in the control of lipid metabolism, immunity, and heart function. Consequently, a picture has emerged of bile acids acting as integrators and modulators of cardiometabolic pathways, highlighting their potential as therapeutic targets in CVD. In this review, we provide an overview of alterations in the gut microbiota and bile acid metabolism found in CVD patients, describe the molecular mechanisms through which bile acids may modulate CVD risk, and discuss potential bile-acid-based treatment strategies in relation to CVD.